Discovery of aryltrifluoroborates as potent sodium/iodide symporter (NIS) inhibitors

ChemMedChem

Volumn 3, Issue 8, 2008, Pages 1207-1209

  Lecat Guillet, Nathalie ^a   Ambroise, Yves ^a  

^a SERVICE DE CHIMIE BIOORGANIQUE ET DE MARQUAGE   (France)

Author keywords

Biological activity; Drug design; Inhibitors; Iodine; Sodium iodide symporter

Indexed keywords

BORIC ACID; COTRANSPORTER; FLUORINE DERIVATIVE; IODIDE; SODIUM IODIDE SYMPORTER;

ANIMAL; ARTICLE; CELL LINE; CHEMICAL STRUCTURE; CHEMISTRY; DRUG ANTAGONISM; DRUG SCREENING; METABOLISM; RAT; STRUCTURE ACTIVITY RELATION;

ANIMALS; BORATES; CELL LINE; DRUG EVALUATION, PRECLINICAL; FLUORINE COMPOUNDS; IODIDES; MOLECULAR STRUCTURE; RATS; STRUCTURE-ACTIVITY RELATIONSHIP; SYMPORTERS;

EID: 54449092379     PISSN: 18607179     EISSN: 18607187     Source Type: Journal    
DOI: 10.1002/cmdc.200800049     Document Type: Article

References (20)

1. O. Dohan, A. De La Vieja, V. Paroder, C. Riedel, M. Artani, M. Reed, C. S. Ginter, N. Carrasco, Endocr. Rev. 2003, 24, 48-77.
2. a) G. Dai, O. Levy, N. Carrasco, Nature 1996, 379, 458-460;
3. b) P. A. Smanik, Q. Liu, T. L. Furminger, K. Ryu, S. Xing, E. L. Mazzaferri, S. M. Jhiang, Biochem. Biophys. Res. Commun. 1996, 226, 339-345.
4. O. Levy, A. De La Vieja, C. S. Ginter, C. Riedel, G. Dai, N. Carrasco, J. Biol. Chem. 1998, 273, 22657-22663.
5. a) C. Riedel, O. Levy, N. Carrasco, J. Biol. Chem. 2001, 276, 21458-21463;
6. b) D. D. Vadysirisack, E. S. W. Chen, Z. Zhang, M. D. Tsai, G. D. Chang, S. M. Jhiang, J. Biol. Chem. 2007, 282, 36820-36828.
7. C. Schmutzler, J. Köhrle, Exp. Clin. Endocrinol. Diabetes 1998, 106-(Suppl. 3), S1-S10.
8. G. Riesco-Eizaguirre, P. Santisteban, Eur. J. Endocrinol. 2006, 155, 495-512.
9. a) N. Lecat-Guillet, G. Merer, R. Lopez, T. Pourcher, B. Rousseau, Y. Ambroise, Assay Drug Dev. Technol. 2007, 5, 535-540;
10. b) N. Lecat-Guillet, G. Merer, R. Lopez, T. Pourcher, B. Rousseau, Y. Ambroise, ChemBioChem 2008, 9, 889-895.
11. a) J. Wolff, Physiol. Rev. 1964, 44, 45-90;
12. b) P. A. Jones, R. U. Pendlington, L. K. Earl, R. K. Sharma, M. D. Barrat, Toxicol. in vitro 1996, 10, 149-160;
13. c) O. Dohan, C. Portulano, C. Basquin, A. Reyna-Neyra, L. M. Amzel, N. Carrasco, Proc. Natl. Acad. Sci. USA 2007, 104, 20250-20255.
14. a) M. Anbar, S. Guttmann, Z. Lewitus, Nature 1959, 183, 1517-1518;
15. b) M. Anbar, S. Guttmann, Z. Lewitus, Endocrinology 1960, 66, 888-890;
16. c) M. Anbar, M. Inbar, Acta Endocrinol. 1964, 46, 639-642.
17. S. Darses, J.-P. Genet, Chem. Rev. 2008, 108, 288-325.
18. G. A. Molander, C.-S. Yun, M. Ribagorda, B. Biolatto, J. Org. Chem. 2003, 68, 5534-5539.
19. 4 were also tested. As expected, we found that the nature of the cation had no influence on RAIU inhibition.
20. 4, 18, 19, and 20, respectively.